Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Novel compounds for vitamin D-dependent disorders in development at Roche

May 31, 1999

AxyS initiates phase II human clinical trials of APC-2059 for treatment of psoriasis

May 28, 1999

Antiacne drug candidate available for licensing from Shire

May 27, 1999

Biogen's Amevive shows excellent results in phase II psoriasis study

May 27, 1999

FDA advisory panel review of Levulan to be rescheduled

May 24, 1999

Compounds for promoting hair growth or regrowth disclosed by Shiseido

May 24, 1999

OSI and Pfizer enter license agreement to develop psoriasis treatment

May 24, 1999

Gliatech files IDE for ADCON-A antiadhesion barrier

May 13, 1999

New antiinflammatory/analgesic agents with both topical and oral activity

May 10, 1999

Clarion discloses new wound-healing agents in development

May 7, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...